NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 1.170
-0.010 (-0.85%)
Apr 24, 2026, 5:04 PM CET
NextCell Pharma AB Market Cap
NextCell Pharma AB has a market cap or net worth of 130.33 million as of April 24, 2026. Its market cap has decreased by -36.99% in one year.
Market Cap
130.33M
Enterprise Value
104.30M
Revenue
9.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.17
Market Cap Chart
Since July 13, 2017, NextCell Pharma AB's market cap has increased from 33.03M to 130.33M, an increase of 294.63%. That is a compound annual growth rate of 16.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 130.33M | 60.05% |
| Dec 30, 2025 | 81.43M | -60.77% |
| Dec 30, 2024 | 207.58M | 129.58% |
| Dec 29, 2023 | 90.42M | -62.64% |
| Dec 30, 2022 | 242.03M | -9.28% |
| Dec 30, 2021 | 266.79M | -35.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diamyd Medical AB | 194.97M |
| Active Biotech AB | 179.52M |
| Elicera Therapeutics AB | 162.35M |
| AlzeCure Pharma AB | 153.99M |
| Alligator Bioscience AB | 153.89M |
| IRLAB Therapeutics AB | 125.03M |
| Simris Group AB (PUBL) | 120.67M |
| Annexin Pharmaceuticals AB | 106.59M |